| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 44 |
| 1 | RISPERIDONE | 43 |
| 2 | QUETIAPINE | 37 |
| 3 | ARIPIPRAZOLE ORAL | 22 |
| 4 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 22 |
| 5 | ESCITALOPRAM | 21 |
| 6 | ESCITALOPRAM OXALATE | 20 |
| 7 | ESCITSLOPRAM | 20 |
| 8 | CITALOPRAM | 18 |
| 9 | CITALOPRAM HYDROBROMIDE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE HCL | 8 | 0.0030 |
| 1 | MEFENAMIC ACID | 6 | 0.0027 |
| 2 | MITOTANE | 2 | 0.0011 |
| 3 | ESTAZOLAM | 2 | 0.0010 |
| 4 | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | 0.0010 |
| 5 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 4 | 0.0008 |
| 6 | HALOPERIDOL DECANOATE | 1 | 0.0006 |
| 7 | RISPERIDONE | 43 | 0.0006 |
| 8 | ZIPRASIDONE | 2 | 0.0006 |
| 9 | LITHIUM | 13 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 96 |
| 1 | Benzodiazepine [EPC] | 24 |
| 2 | Serotonin Reuptake Inhibitor [EPC] | 19 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 4 | Mood Stabilizer [EPC] | 12 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 11 |
| 6 | Anti-epileptic Agent [EPC] | 11 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 10 |
| 8 | Factor Xa Inhibitor [EPC] | 9 |
| 9 | Insulin Analog [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 1 | Typical Antipsychotic [EPC] | 7 | 0.0003 |
| 2 | Atypical Antipsychotic [EPC] | 96 | 0.0002 |
| 3 | Serotonin Reuptake Inhibitor [EPC] | 19 | 0.0002 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 11 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Mood Stabilizer [EPC] | 12 | 0.0001 |
| 8 | Anti-epileptic Agent [EPC] | 11 | 0.0000 |
| 9 | Benzodiazepine [EPC] | 24 | 0.0000 |